Mehmet Uğur Bilgin

Mehmet Uğur Bilgin

Auto-generated profile, based on publicly available information

Mehmet Uğur Bilgin

Teaching Hosp Univ Kiel, Clin Anesthesiol & Reanimat, Helios Klinikum Schleswig, Kiel, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2023 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Open access
MBMehmet Uğur Bilgin
Mehmet Uğur Bilgin
ZTzeki tuncel Tekgül
zeki tuncel Tekgül
TDTansu Değirmenci
Tansu Değirmenci
Objective: Percutaneous nephrolithotomy (PCNL) is accompanied by somatic and visceral pain intraoperatively and postoperatively. However, pain management strategies lack a decisive consensus. Erector spinae plane block (ESPB) is a novel paraspinal fascial block that can be used in PCNL patients, and we aimed to investigate whether ESPB will reduce intraoperative and postoperative opioid consumption and postoperative pain scores in PCNL patients. Methods: The study was randomized, controlled, and open-label. Two groups were formed as the control group (GCont) and block group (Gblock), and patients received total intravenous anaesthesia. GBlock received an ESPB catheter in addition in the prone position. Intraoperative parameters and infusion doses, postoperative rescue analgesic doses, and pain scores were recorded. The primary endpoint was intraoperative analgesic consumption, and the secondary endpoints were postoperative pain scores and analgesic consumption. Results: Sixty-four patients were analyzed. Remifentanil consumption of GCont was found to be significantly higher (GBlock: 0.0865 +/- 0.030 vs GCont: 0.1398 +/- 0.034, mu g kg(-1) min(-1), P < 0.001). The control group reported higher pain scores between the 30th min and 24th hours and needed more analgesics between the 1st and 6th hours postoperatively. GBlock received local anaesthetics via ESPB catheter before nephrostomy tube removal and fewer patients needed analgesics [5 patients (15.6%) vs. 28 patients (87.5%), P < 0.001]. GCont consumed more tramadol postoperatively (262.5 mg vs. 75 mg, P < 0.001). Conclusion: We found that ESPB reduced intraoperative opioid consumption. It also reduced the need for rescue analgesia and postoperative pain scores during nephrostomy tube removal. We concluded that the ESPB catheter may effectively be used in analgesia management during and after PCNL operations.

20 October 2023 in Balkan Medical Journal
Verified
Journal Article
Open access
HÖHüseyin Özkarakaş
Hüseyin Özkarakaş
ZTzeki tuncel Tekgül
zeki tuncel Tekgül
MAMurat Arslan
Murat Arslan
MBMehmet Uğur Bilgin
Mehmet Uğur Bilgin
HEHazal Ezgi Eker
Hazal Ezgi Eker
BÇBülent Çalık
Bülent Çalık
Background: Increased intra-abdominal pressure (IAP) in patients admitted to the intensive care unit leads to reduced abdominal perfusion pressure (APP), causing circulatory insufficiency and organ failure.Aims: To investigate the effect of maintaining a targeted APP on renal injury and the effect of increased IAP on the mortality rate in patients with septic shock.Study Design: Randomized, controlled, open-label study.Methods: A total of 72 patients were randomly divided into two groups (MAP65 or APP60). The MAP target for patients in the MAP65 group (n = 36) was 65 mmHg according to the Surviving Sepsis Guidelines. In the APP60 group (n = 36), the target APP was set to > 60 mmHg. The glomerular filtration rate (GFR), inotrope consumption, and IAP were recorded daily. The need for renal replacement therapy, decrease in GFR, and 30-and 90-day mortality rates were compared between the two groups.Results: In both the groups, the IAP was statistically similar (p = 0.458). The decreased in GFR was similar in both groups during the first 2 days. From day 3, there was a more statistically significant rapid decline in GFR in the MAP65 group than in the APP60 group. The GFR p-values on the 3rd, 4th, and 5th days were 0.040, 0.043, and 0.032, respectively. Eight patients (22.2%) in the MAP65 group and three patients (8.3%) in the APP group required renal replacement therapy (p = 0.101). The 30-day mortality rates in the MAP65 and APP60 groups were 61.1%, and 47.7%, respectively (p = 0.237). The 90-day mortality rates in the MAP65 and APP60 groups were 66.7% and 66.7%, respectively (p = 1).Conclusion: Setting an APP target limited the reduction in GFR. The mortality rates were similar in the two groups and there was no difference in the rate of end-stage renal failure between the groups.

14 February 2022 in Ain-Shams Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
ZTzeki tuncel Tekgül
zeki tuncel Tekgül
MBMehmet Uğur Bilgin
Mehmet Uğur Bilgin
CKCemil Kayali
Cemil Kayali
Background Femoral nerve block (FNB) is a suitable option for pain management and recovery after total knee arthroplasty (TKA). It is usually used along with a multimodal analgesia protocol. The major disadvantage of FNB is the risk of quadriceps muscle strength loss. This study aims to compare the efficiency of the FNB with two different concentrations of bupivacaine for recovery after TKA. We primarily aim to provide adequate analgesia with a lower concentration of bupivacaine (0.125%) rather than the usual concentration (0.25%). Secondarily, we aim to compare the degree of motor block, opioid consumption, and ambulation time between the groups. The study was conducted as randomized, controlled, and double-blind. Sixty three patients were randomized into three groups: G125 (n:21) received FNB with 20ml of 0,125% bupivacaine, G25 (n:21) received 10ml of 0,25% bupivacaine and GCont (n:21) received no block. Results For GCont, pain scores were significantly higher at 2nd, 6th, 12th, and 24th hours postoperatively, total opioid consumption was higher (G125: 75 mg, G25: 0 mg, GCont: 280 mg, p < 0.001) and first opioid demand time was earlier (G125: 12th hour, G25:21st hour GCont:2nd hour, p: 0.002). First knee flexion time and ambulation time were also delayed for GCont. G25 had lower scores for quadriceps muscle strength (manual test at 6th hour, G25: 3/5, G125: 4/5, GCont:5/5, p < 0.001) compared to other groups. Conclusions G125 had lower quadriceps muscle strength loss compared to the G25; earlier ambulation and flexion times, low opioid consumption, and low pain scores compared to the control group. In this respect, we believe the femoral nerve block with 0.125% bupivacaine proves to be a suitable option for analgesia with the potential of maintaining enough muscle strength for recovery after TKA. Trial registration ClinicalTrials.gov Protocol Registration and Results System, NCT03623230. Registered 09 August 2018, at https://clinicaltrials.gov/ct2/show/NCT03623230

3 May 2021
Verified
Preprint
Open access
PDF file
ZTzeki tuncel Tekgül
zeki tuncel Tekgül
MBMehmet Ugur Bilgin
Mehmet Ugur Bilgin
CKCemil Kayali
Cemil Kayali
Purpose The aim of our study is to evaluate the efficiency of femoral nerve block on recovery after primary total knee arthroplasty. Our primary goal is to provide adequate analgesia with a lower concentration of bupivacaine (0.125%) as well as the usual concentration (0.25%). Comparing the degree of motor block, side effects, postoperative pain scores, opioid consumption, and ambulation and discharge times are our secondary goals. Methods The study was conducted as randomized, controlled and double blind. Sixty three patients were randomised into three groups: G125(n:21) received FNB with 20ml of 0,125% bupivacaine, G25(n:21) received 10ml of 0,25% bupivacaine and GCont(n:21) received no block. FNB was applied with ultrasound guidance after the operation. Pain scores(NRS) at certain time intervals, total opioid consumption, motor block, knee flexion and discharge times were recorded. Results For GCont, pain scores were significantly higher at 2nd, 6th, 12th and 24th hour postoperatively, total opioid consumption was higher(G125:75mg, G25:0mg, GCont:280mg) and first opioid demand time was earlier(G125:12th hour, G25:21st hour GCont:2nd hour). First knee flexion time and mobilization time were also delayed for GCont. G25 had lower scores for quadriceps muscle strength(G25:3/5, G125:4/5, GCont:5/5, Manual Test at 6th Hour), but this did not affect mobilization compared to G125. Conclusion G125 had lower quadriceps muscle strength loss compared to the G25 and earlier mobilization and flexion times, low opioid consumption and low pain scores compared to the control group. In this respect, we believe the femoral nerve block with 0,125% bupivacaine proves to be a suitable option for analgesia with the potential of maintaining enough movement for recovery after TKA.